Cymbiotika Launches Liposomal Beauty Peptide Complex for Skin, Hair, Nails

Clean-label wellness brand Cymbiotika has launched Liposomal Beauty Peptide Complex, a ready-to-drink nutricosmetic aimed at skin, hair, and nails with clinically studied collagen and ceramides delivered through liposomal sachets. PR Newswire carried the company’s Sept. 14 announcement from San Francisco, positioning the raspberry-flavored daily ritual as a “beauty from within” answer to the limits of topical-only routines.

Nutraceutical Business Review, publishing Sept. 15 coverage, independently detailed the same formula stack: GELITA’s VERISOL bioactive collagen peptides, Seppic’s Ceramosides, hyaluronic acid, essential minerals, and amino acids, plus tripeptides, zinc, copper, and silica. Both outlets emphasize progressive, time-stamped benefit claims tied to the hero ingredients rather than a single vague “glow” promise.

According to the clinical timeline Cymbiotika cites — and both trade sources reproduce — Ceramosides are linked to improved hydration and reduced appearance of fine lines after two weeks; VERISOL is tied to improved elasticity at four weeks; the collagen–ceramide pairing is framed as supporting healthier, stronger hair by eight weeks; and continued VERISOL use is associated with stronger nail growth by twelve weeks. Those checkpoints matter for a category crowded with collagen powders that rarely spell out a week-by-week arc.

Co-founder and CEO Durana Elmi cast the launch as more than “another collagen supplement.” In remarks quoted by PR Newswire and NBR, she said consumers “want clinically-backed formulations that deliver real, visible results,” and that Beauty Peptide Complex was built so ingredients “work together” across skin, hair, and nails in one daily step. Liposomal encapsulation — wrapping actives in a lipid layer for stability through digestion — is the brand’s absorption pitch, with sachets designed for morning, midday, or evening use beside existing skincare.

Pricing and retail path are concrete. PR Newswire listed availability on Cymbiotika.com from Sept. 14 at $74 for 26 packets, with 12-packs, 3-packs, and singles rolling to retailers later in the fall. Ulta Beauty is slated to begin Sept. 27, ahead of broader mass and natural channels in October — a sequence that puts a clinic-leaning ingestible into the same specialty beauty aisle that has been absorbing wellness SKUs all year.

Category context helps explain the timing. NBR noted Cymbiotika’s recent placement on the 2026 Inc. 5000 list of fastest-growing U.S. private companies, while PR Newswire framed collagen decline with age as the proactive hook: support the body’s beauty processes through nutrition instead of relying solely on creams. That message aligns with a wider nutricosmetic boom in which ceramides, bioactive peptides, and hyaluronic acid migrate from derm shelves into drinkable formats.

Shoppers should still treat marketing timelines as brand-reported research summaries, not personalized medical advice. Interactions, dietary restrictions, and bovine collagen sourcing can matter; anyone with health conditions or who is pregnant should check with a clinician before adding a daily peptide sachet. The clean-label framing and raspberry flavor are convenience features, not substitutes for evidence a consumer should verify against the cited ingredient studies.

For beauty-retail desks watching wellness blur into mascara aisles, the dual Sept. 14–15 record from PR Newswire and Nutraceutical Business Review is straightforward: a liposomal collagen–ceramide complex with a published two-to-twelve-week claim ladder, a $74 direct-to-consumer entry price, and an Ulta handoff at month’s end. Whether the format sticks will depend on repurchase after the first box — but the launch package is built for that exact test.